Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Dryvax Smallpox Vaccine Approved For 100-Dose Kit, 30-Day Expiration

Executive Summary

Wyeth's Dryvax may be used for up to 30 days after reconstitution following a supplemental approval for the smallpox vaccine

You may also be interested in...



Smallpox Sequela FDA Draft Guidance Recommends Data Collection Systems

An FDA draft guidance on developing drugs to treat complications associated with smallpox vaccination lists data collection recommendations for pre-terrorism events, post-terrorism events and post-approval

Smallpox Sequela FDA Draft Guidance Recommends Data Collection Systems

An FDA draft guidance on developing drugs to treat complications associated with smallpox vaccination lists data collection recommendations for pre-terrorism events, post-terrorism events and post-approval

Next-Gen Smallpox, Anthrax Vaccines To Be First Use Of Animal Efficacy

A next-generation smallpox vaccine is expected to be the first product licensed under FDA's animal efficacy rule, HHS Office of the Assistant Secretary for Public Health Emergency Preparedness Senior Advisor Philip Russell, MD, said Aug. 28

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040783

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel